// STATE LEGISLATION TRACKER

Arizona HB 2415 — kratom products; narcotic drugs

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Arizona
Bill: HB 2415
Filed: 2026-01-15
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Arizona HB2415 appears to address kratom products and narcotic drug classification, not peptides, compounding, telehealth, or clinician prescribing scope. Based only on the title, subjects, and unavailable latest-action data, it has no direct peptide-ecosystem impact.

Key Points

No direct signal of changes to compounded peptide access
No apparent change to off-label prescribing rules
No apparent telehealth or clinician-scope change
Controlled-substance focus appears limited to kratom/narcotics

What to Watch For

Note If text becomes available, check whether any broad controlled-substance language reaches peptide prescribing.

Note Watch for amendments that add pharmacy, compounding, or prescription-monitoring language.

Where the Bill Stands

The source lists the latest action as unavailable because the OpenStates refetch failed, so the bill's process status cannot be confirmed from the provided data.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws